🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study of HB-202/HB-201 alternating 2-vector therapy with pembroli...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06513884
Treatments Being Tested
This is a Phase 2 clinical trial with a 2:1 randomization comparing neoadju...
Status
Recruiting
Location
University of California, Irvine
Start Date
2025-08-21
Trial ID
NCT06624475
Treatments Being Tested
The present study has 5 parts. In Parts A and A1, the dose of intravenous (...
Status
Completed
Location
Multiple Locations
Start Date
2011-03-04
Trial ID
NCT01295827
Treatments Being Tested
The primary objective is to determine if mutation load underlies sensitivit...
Status
Terminated
Location
Columbia University
Start Date
2016-05-31
Trial ID
NCT02710396
Treatments Being Tested
To evaluate the safety and efficacy of PD-1 immune checkpoint inhibitor com...
Status
Unknown
Location
Yanqun Xiang
Start Date
2022-03-12
Trial ID
NCT05229315
Treatments Being Tested
After a stroke, it is very common to lose the ability to open the affected ...
Status
Completed
Location
Emory University and Atlanta VA
Start Date
2019-02-15
Trial ID
NCT03574623
Treatments Being Tested
Abstract: Objective: To examine the effect of low-frequency acupoint elect...
Status
Completed
Location
Low-Frequency Acupoint Electrical Stimulation
Start Date
2022-01-01
Trial ID
NCT06061731
Treatments Being Tested
In order to search for predictors of response to chemotherapy in patients w...
Status
Completed
Location
Centre Eugène Marquis
Start Date
2011-06
Trial ID
NCT01391351
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of intratumo...
Status
Completed
Location
UCLA Hematology & Oncology ( Site 0005)
Start Date
2020-03-04
Trial ID
NCT04220866
Treatments Being Tested
This is a randomized, double-blind, study that compares pembrolizumab (MK-3...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 1562)
Start Date
2019-04-01
Trial ID
NCT03833167
Treatments Being Tested